A compound attribute that is the ratio of amount of tumor necrosis factor receptor superfamily member EDAR (human) in blood to amount of integrin beta-1-binding protein 2 (human) in blood. The trait is EDAR/ITGB1BP2 protein level ratio in blood (OBA_2055624). Also known as: the ratio of amount of tumor necrosis factor receptor superfamily member EDAR (human) in blood to amount of integrin beta-1-binding protein 2 (human) in blood.